Among other K+ channels [15], the Ca2+-activated K+ channel (KCa) subfamily members of the big (BK) and intermediate (IK aka IKCa, KCNN4, KCa3.1 or SK4) type have been proposed as therapeutic targets in breast cancer (BC) [22, 23]. Here, KCNN4 is linked to breast carcinoma.